3B BlackBio Dx Ltd — Important, 19-02-2026: Company Update

3B BlackBio Dx Limited's CEO communicated with shareholders, apologizing for rescheduling a recent call due to illness. The CEO provided an update on the company's participation in MEDLAB Dubai, where their TRUPCR and 3B brands achieved global recognition. The event yielded 2-3 interesting leads for potential mergers and acquisitions. Coris, a company next to their booth, also received strong inquiries, especially in Antimicrobial Resistance, its key strength. Competitors acknowledged 3B's tough market presence, reflecting the success of their customer-centric approach. This positive feedback from global visitors affirms the company's strategy and commitment to growth.